These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5927754)

  • 1. Pathogenesis of a virus-induced rhabdomyosarcoma in mice.
    Perk K; Moloney JB
    J Natl Cancer Inst; 1966 Nov; 37(5):581-99. PubMed ID: 5927754
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of a rhabdomyosarcoma (undifferentiated type) in rats induced by a murine sarcoma virus (Moloney).
    Perk K; Shachat DA; Moloney JB
    Cancer Res; 1968 Jun; 28(6):1197-206. PubMed ID: 5658448
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the enzymology of the rhabdomyosarcoma induced by the murine sarcoma virus (Moloney).
    Ebert PS; Chirigos MA; Chan SP
    Cancer Res; 1970 Apr; 30(4):960-5. PubMed ID: 4251322
    [No Abstract]   [Full Text] [Related]  

  • 4. A virus-induced rhabdomyosarcoma of mice.
    Moloney JB
    Natl Cancer Inst Monogr; 1966 Sep; 22():139-42. PubMed ID: 4288557
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative dose-response relationships of murine sarcoma virus (Moloney) in BALB/c mice.
    Blumenschein GR; Moloney JB
    J Natl Cancer Inst; 1969 Jan; 42(1):123-33. PubMed ID: 5765223
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of childhood rhabdomyosarcoma and virus-induced rhabdomyosarcoma in mice.
    Freeman AI; Johnson WW
    Cancer Res; 1968 Aug; 28(8):1490-500. PubMed ID: 4877806
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Effects of prolactin and bromocriptine on the response to Moloney sarcoma virus in mice.
    Karmali RA; Horrobin DF
    J Endocrinol; 1975 Nov; 67(2):57P-58P. PubMed ID: 1206305
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Giuliani F; Casazza AM; Di Marco A
    Biomedicine; 1973 Sep; 18(5):387-92. PubMed ID: 4752705
    [No Abstract]   [Full Text] [Related]  

  • 9. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. I. Biologic and immunogenic studies.
    Law LW; Ting RC; Stanton MF
    J Natl Cancer Inst; 1968 May; 40(5):1101-12. PubMed ID: 5648135
    [No Abstract]   [Full Text] [Related]  

  • 10. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental infection of newborn mice with toxoplasma and Moloney virus.
    Huldt G; Gard S
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(3):441. PubMed ID: 5283062
    [No Abstract]   [Full Text] [Related]  

  • 12. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
    Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
    Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of polycythemia-inducing Friend leukemia virus and Moloney leukemia virus on hematopoietic progenitors in murine long-term bone marrow cultures.
    Heard JM; Fichelson S; Gisselbrecht S; Varet B
    Cancer Res; 1981 Aug; 41(8):3260-5. PubMed ID: 6972804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of defective MSV from a non-infectious neoplasm of the mouse induced by MSV(MLV).
    Law LW; Ting RC; Duc-Nguyen H
    Rev Eur Etud Clin Biol; 1970 May; 15(5):532-3. PubMed ID: 5464313
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
    Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effects of amino acid derivatives with the fluorene substituent on murine leukemia viruses.
    Fujita H; Toyoshima S
    J Natl Cancer Inst; 1983 Feb; 70(2):275-8. PubMed ID: 6571936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemogenesis by Moloney murine leukemia virus: a multistep process.
    Fan H
    Trends Microbiol; 1997 Feb; 5(2):74-82. PubMed ID: 9108934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.